Published in Medical Letter on the CDC and FDA, June 6th, 2010
"We are encouraged to see that protecting patients from the potential dangers posed by unapproved drugs is still a top priority for Sen. Grassley," said Dr. Puckrein. "We agree that it is important for the FDA to create an inventory of the unapproved drugs in the U.S., but it is as important to recognize that there is much the agency can do today without this legislation. This...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA